A61P 15/02
Drugs for genital or sexual disorders: for disorders of the vagina
Official title: for disorders of the vagina
A61P15/02 (Drugs for genital or sexual disorders: for disorders of the vagina) appears on 1,125 US grants and 1,831 published applications in this corpus.
Search patents in A61P- Granted patents
- 1,125
- Published applications
- 1,831
- Assignees
- 724
- Inventors
- 2,658
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 6 | 0 |
| 1996 | 2 | 0 |
| 1997 | 5 | 0 |
| 1998 | 16 | 0 |
| 1999 | 15 | 0 |
| 2000 | 18 | 0 |
| 2001 | 24 | 8 |
| 2002 | 32 | 41 |
| 2003 | 23 | 60 |
| 2004 | 13 | 47 |
| 2005 | 16 | 61 |
| 2006 | 24 | 77 |
| 2007 | 25 | 67 |
| 2008 | 33 | 87 |
| 2009 | 25 | 92 |
| 2010 | 56 | 128 |
| 2011 | 45 | 108 |
| 2012 | 59 | 120 |
| 2013 | 54 | 86 |
| 2014 | 86 | 86 |
| 2015 | 72 | 97 |
| 2016 | 59 | 67 |
| 2017 | 56 | 82 |
| 2018 | 57 | 76 |
| 2019 | 58 | 91 |
| 2020 | 60 | 75 |
| 2021 | 50 | 71 |
| 2022 | 42 | 54 |
| 2023 | 25 | 38 |
| 2024 | 32 | 47 |
| 2025 | 23 | 38 |
| 2026 | 14 | 27 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for increasing epithelial barrier function15 Sep 2026US 12,734,214 B2The Board of Trustees of the Leland Stanford Junior University
- Vaginal hydrogel8 Sep 2026US 12,728,166 B2
- Methods of preparing anti-human papillomavirus antigen T cells11 Aug 2026US 12,702,706 B2The United States of America, as represented by the Secretary, Department of Health and Human Seervices
- Lopinavir and ritonavir for the treatment of cervix disorders14 Jul 2026US 12,678,439 B2Douglas Pharmaceuticals Limited
- Microbiome compositions16 Jun 2026US 12,653,846 B2B.Y.M. Technologies
- Compositions and methods for treating vulvar and vaginal atrophy (vva)1 Oct 2026US 2026/0294846 A1
- Substituted pyrimidinone and azapyrimidinone compounds, compositions, and uses thereof1 Oct 2026US 2026/0297118 A1
- Probiotic with efficacy in improving vaginitis, compound microecological preparation, and application thereof17 Sep 2026US 2026/0273000 A1Ningbo University
- Microbiome-based informed method to formulate live biotherapeutics20 Aug 2026US 2026/0240920 A1University of Maryland, Baltimore
- Composition comprising recombinant clostridium neurotoxin20 Aug 2026US 2026/0240963 A1Ipsen Bioinnovation Limited
Most cited
By later US patents
- Inhibitors of bruton's tyrosine kinase306US 7,514,444 B2Pharmacyclics, Inc. · 2009
- Formulations and methods for treatment of mucosal associated conditions with an immune response modifier272US 6,245,776 B13M Innovative Properties Company · 2001
- Treatment of female sexual dysfunction233US 6,294,550 B1Asivi, LLC · 2001
- Treatment of female sexual dysfunction212US 6,306,841 B1Asivi, LLC · 2001
- Methods for using tetanus toxin for beneficial purposes in animals (mammals)171US 7,494,661 B22009